Press release
Global mRNA Vaccines and Therapeutics Market Size, Share, Demand, Trends, Growth and Forecast Analysis Report to 2021-2026
Get a report sample: https://www.marknteladvisors.com/query/request-sample/global-mrna-vaccines-and-therapeutics-market.html
Market Segmentation
1. By mRNA Type (Nucleoside-Modified mRNA (modRNA), Unmodified mRNA, Self-Amplifying mRNA)
2. By Application Type (COVID mRNA Application [Commercialised Vaccine {mRNA-1273, BNT162b2}, Pipeline Vaccines {CVnCoV, LUNAR-COV19, MRT5500, DS-5670}] Non-COVID mRNA Application [Immuno-Oncology, Cardiology, Endocrinology, Haematology, Other infectious & rare diseases])
3. By End-User (Hospitals & healthcare Clinics, Research Organization & Institutions, Others)
For detailed analysis: https://www.marknteladvisors.com/research-library/global-mrna-vaccines-and-therapeutics-market.html
Region-wise Segmentation
• North America: US, Canada, Mexico
• South America: Brazil, Argentina
• Europe: Germany, France, The U.K, Spain, Italy
• Asia-Pacific: China, India, Japan, Australia, South Korea
• Middle East & Africa: Saudi Arabia, UAE, South Africa
Key Growth Drivers
• the rising prevalence of infectious & chronic diseases, including HIV, diabetes, cancer, and cardiovascular diseases.
• the inability of the traditional vaccine approaches to perform at a critical time
• mRNA vaccines & therapeutics getting developed with advanced technologies to achieve high effectiveness
Share your requirements: https://www.marknteladvisors.com/query/request-customization/global-mrna-vaccines-and-therapeutics-market.html
Market Challenges
• transporting mRNA vaccines from manufacturing sites to vaccination centers
• lack of proper infrastructure to stockpile mRNA-based COVID-19 vaccines
Market Competitors:
Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, Translate Bio, Versameb AG, Verve Therapeutics, Inc.
Key Questions Answered in this Report:
1. What are the current & future trends in the Global mRNA Vaccines and Therapeutics Market?
2. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global mRNA Vaccines and Therapeutics Market?
3. How has the industry been evolving in terms of geography & services adoption?
4. How has the competition been shaping across the globe, followed by their comparative factorial indexing?
5. What are the key growth drivers & challenges for the Global mRNA Vaccines and Therapeutics Market?
6. What are the customer orientation, purchase behavior, and expectations from mRNA Vaccines & Therapeutics providers across the globe?
7. What are the region-wise industry size, growth drivers, and challenges?
8. What are the key innovations, opportunities, current & future trends, and regulations in the Global mRNA Vaccines and Therapeutics Market?
9. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global mRNA Vaccines and Therapeutics Market based on a competitive benchmarking matrix?
10. What are the key results derived from the market surveys conducted during the Global mRNA Vaccines and Therapeutics Market study?
MarkNtel Advisors
1147 88AVE, Delta, British Columbia, BC,V4C,3B8, CANADA
Email: sales@marknteladvisors.com
Tel: +1 604 800 2671
Website: https://www.marknteladvisors.com
About us:
MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.
We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global mRNA Vaccines and Therapeutics Market Size, Share, Demand, Trends, Growth and Forecast Analysis Report to 2021-2026 here
News-ID: 2388280 • Views: …
More Releases from MarkNtel Advisors LLP
Saudi Arabia Halal Food Market Poised for Growth: 6.48% CAGR Forecasted Through …
Introduction
The Saudi Arabia Halal Food Market is on the rise, expected to reach a market size of USD 63.28 billion by 2030, growing from USD 46.22 billion in 2025. Driven by a compound annual growth rate (CAGR) of approximately 6.48%, this growth is bolstered by several key factors, including a predominantly Muslim population, robust government support, an expanding retail sector, and a surge in tourism and hospitality. The evolving consumer…
Saudi Arabia Energy Management Market Set to Achieve 11.67% CAGR by 2030 Driven …
Introduction
The Saudi Arabia Energy Management Market is evolving rapidly, valued at approximately USD 298 million in 2025, with a robust compound annual growth rate (CAGR) of 11.67% anticipated until 2030. This impressive growth trajectory is significantly driven by the Saudi government's vigorous agenda promoting energy efficiency, the increasing integration of renewable energy sources, and advancements in technology, such as artificial intelligence. As the nation shifts towards smarter energy consumption practices,…
GCC Ginger Market Revenue Expected to Reach USD 122 Million by 2030 | Major Play …
Executive Summary
The GCC Ginger Market is poised for robust growth, driven by increasing health consciousness and a diverse expatriate population. Valued at approximately USD 88.29 million in 2025, the market is projected to reach USD 122 million by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 6.68% from 2025 to 2030. Key government initiatives aiming at promoting healthier lifestyles further bolster this trend, positioning ginger as a staple in…
Asia-Pacific Ginger Market to Reach USD 2.55 Billion by 2030 | Key Players Inclu …
Executive Summary
The Asia-Pacific Ginger Market is poised for significant growth, with a projected size of USD 2.55 billion by 2030, up from USD 1.89 billion in 2025. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.17% from 2025 to 2030, driven by increasing consumer awareness about health benefits, government support initiatives, and a growing demand for organic products. The region's climatic advantages further enhance ginger cultivation, ensuring…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
